Skip to main content
. 2023 Apr 14;14:1149874. doi: 10.3389/fimmu.2023.1149874

Figure 1.

Figure 1

Size Exclusion Chromatography (SEC) of immunocomplexes of TNFα with ozoralizumab or adalimumab. (A) chromatograms of ozoralizumab-TNFα mixtures in various molar ratios. (B) chromatograms of adalimumab-TNFα mixtures in various molar ratios. All molecular weights were estimated by calibration with molecular weight markers.